UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis

Addiction (Abingdon, England), 2016-04, Vol.111 (4), p.599-612

2016

Volltextzugriff (PDF)

Addressing Barriers to Provision of First-Line Pharmacotherapy for Tobacco Use Disorder

Psychiatric services (Washington, D.C.), 2023-04, Vol.74 (4), p.429-430

2023

Volltextzugriff (PDF)

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

The Lancet (British edition), 2016-06, Vol.387 (10037), p.2507-2520

2016

Volltextzugriff (PDF)

Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed

Neuropsychopharmacology (New York, N.Y.), 2016-01, Vol.41 (2), p.393-401

2016

Volltextzugriff (PDF)

Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder

Addictive behaviors, 2021-02, Vol.113, p.106661-106661, Article 106661

2021

Volltextzugriff (PDF)

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline

American journal of respiratory and critical care medicine, 2020-07, Vol.202 (2), p.e5-e31

2020

Volltextzugriff (PDF)

Alternative combusted tobacco product and multiple tobacco product use among individuals with serious mental illness enrolled in a large pragmatic randomized controlled trial

Addictive behaviors, 2024-01, Vol.148, p.107844-107844, Article 107844

2024

Volltextzugriff (PDF)

Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES

Psychiatric services (Washington, D.C.), 2021-01, Vol.72 (1), p.7-15

2021

Volltextzugriff (PDF)

Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness

Preventive medicine, 2017-11, Vol.104, p.40-45

2017

Volltextzugriff (PDF)

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES

Addiction (Abingdon, England), 2018-08, Vol.113 (8), p.1507-1516

2018

Volltextzugriff (PDF)

Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence

Biological psychiatry (1969), 2010-04, Vol.67 (8), p.722-729

2010

Volltextzugriff (PDF)

Unknown risks of psychosis and addiction with delta‐8‐THC: A call for research, regulation, and clinical caution

Addiction (Abingdon, England), 2022-09, Vol.117 (9), p.2371-2373

2022

Volltextzugriff (PDF)

Cannabis use for medical symptoms: Patterns over the first year of use

Addictive behaviors, 2023-09, Vol.144, p.107719-107719, Article 107719

2023

Volltextzugriff (PDF)

The Developmental Timing but Not Magnitude of Adolescent Risk-Taking Propensity Is Consistent Across Social, Environmental, and Psychological Factors

Journal of adolescent health, 2024-03, Vol.74 (3), p.613-616

2024

Volltextzugriff (PDF)

Substance Use, Suicidal Thoughts, and Psychiatric Comorbidities Among High School Students

JAMA pediatrics, 2024-03, Vol.178 (3), p.310

2024

Volltextzugriff (PDF)

Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging

Neuropsychopharmacology (New York, N.Y.), 2022-03, Vol.47 (4), p.944-952

2022

Volltextzugriff (PDF)

Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth

Drug and alcohol dependence, 2024-03, Vol.256, p.111096-111096, Article 111096

2024

Volltextzugriff (PDF)

Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence

Journal of psychopharmacology (Oxford), 2020-02, Vol.34 (2), p.197-210

2020

Volltextzugriff (PDF)

Early Onset Marijuana Use Is Associated With Learning Inefficiencies

Neuropsychology, 2016-05, Vol.30 (4), p.405-415

2016

Volltextzugriff (PDF)

Sex Differences in Neuropsychological Functioning are Domain-Specific in Adolescent and Young Adult Regular Cannabis Users

Journal of the International Neuropsychological Society, 2021-07, Vol.27 (6), p.592-606

2021

Volltextzugriff (PDF)

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors

Addiction (Abingdon, England), 2021-10, Vol.116 (10), p.2816-2824

2021

Volltextzugriff (PDF)

The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

Psychotherapy and psychosomatics, 2003-05, Vol.72 (3), p.115-127

2003

Volltextzugriff (PDF)

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial

Depression and anxiety, 2020-03, Vol.37 (3), p.247-260

2020

Volltextzugriff (PDF)

Erratum to "Assessing Changes in Sleep Across Four Weeks Among Adolescents Randomized to Incentivized Cannabis Abstinence" [Drug Alcohol Depend. 252 (2023) 110989]

Drug and alcohol dependence, 2023-12, Vol.253, p.111020-111020, Article 111020

2023

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(213)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Englisch
(219)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(166)
Life Sciences & Biomedicine
(162)
Humans
(147)
Psychiatry
(125)
Adult
(103)
Female
(97)
Male
(90)
Middle Aged
(65)
Schizophrenia
(54)
Biological And Medical Sciences
(50)
Medical Sciences
(49)
Smoking Cessation
(46)
Neurosciences & Neurology
(45)
Psychology. Psychoanalysis. Psychiatry
(44)
Double-Blind Method
(43)
Psychology
(42)
Neurosciences
(41)
Social Sciences
(41)
Nicotine
(36)
Psychopathology. Psychiatry
(35)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis

Addressing Barriers to Provision of First-Line Pharmacotherapy for Tobacco Use Disorder

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed

Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline

Alternative combusted tobacco product and multiple tobacco product use among individuals with serious mental illness enrolled in a large pragmatic randomized controlled trial

Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES

Prolonged cannabis withdrawal in young adults with lifetime psychiatric illness

Factors associated with the efficacy of smoking cessation treatments and predictors of smoking abstinence in EAGLES

Brain Reactivity to Smoking Cues Prior to Smoking Cessation Predicts Ability to Maintain Tobacco Abstinence

Unknown risks of psychosis and addiction with delta‐8‐THC: A call for research, regulation, and clinical caution

The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial

Cannabis use for medical symptoms: Patterns over the first year of use

The Developmental Timing but Not Magnitude of Adolescent Risk-Taking Propensity Is Consistent Across Social, Environmental, and Psychological Factors

Substance Use, Suicidal Thoughts, and Psychiatric Comorbidities Among High School Students

Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging

Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth

Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence

Early Onset Marijuana Use Is Associated With Learning Inefficiencies

Sex Differences in Neuropsychological Functioning are Domain-Specific in Adolescent and Young Adult Regular Cannabis Users

Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion and nicotine patch versus placebo: secondary analysis of results from the EAGLES trial using Bayes factors

The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active‐ and placebo‐controlled EAGLES trial

Erratum to "Assessing Changes in Sleep Across Four Weeks Among Adolescents Randomized to Incentivized Cannabis Abstinence" [Drug Alcohol Depend. 252 (2023) 110989]

Suchergebnisse filtern